Home Healthcare Pharmaceuticals Subcutaneous Biologic Market

Subcutaneous Biologic Market Size, Share & Trends Analysis Report By Molecule Class (Monoclonal Antibodies, Peptides/Proteins, Immunoglobulins, Cytokines, Oligonucleotides, Enzymes/Hormones, Others), By Delivery System (Prefilled Syringes, Autoinjector Pens, Wearable Injectors, Vial & Syringes, Prefilled Cartridges for Pens), By Therapy Area (Metabolics, Autoimmune & Inflammatory, Oncology & Hematology, Neurology, Respiratory & Allergy, Rare Diseases & Immunodeficiencies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 17, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Subcutaneous Biologic Market Size Analysis
    1. Introduction
    2. Subcutaneous Biologic Market Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Peptides/Proteins
      3. Immunoglobulins
      4. Cytokines
      5. Oligonucleotides
      6. Enzymes/Hormones
      7. Others
    3. Subcutaneous Biologic Market Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
      1. Prefilled Syringes
      2. Autoinjector Pens
      3. Wearable Injectors
      4. Vial & Syringes
      5. Prefilled Cartridges for Pens
    4. Subcutaneous Biologic Market Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Metabolics
      2. Autoimmune & Inflammatory
      3. Oncology & Hematology
      4. Neurology
      5. Respiratory & Allergy
      6. Rare Diseases & Immunodeficiencies
      7. Others
  7. North America Subcutaneous Biologic Market Size Analysis
    1. Introduction
    2. Subcutaneous Biologic Market Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Peptides/Proteins
      3. Immunoglobulins
      4. Cytokines
      5. Oligonucleotides
      6. Enzymes/Hormones
      7. Others
    3. Subcutaneous Biologic Market Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
      1. Prefilled Syringes
      2. Autoinjector Pens
      3. Wearable Injectors
      4. Vial & Syringes
      5. Prefilled Cartridges for Pens
    4. Subcutaneous Biologic Market Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Metabolics
      2. Autoimmune & Inflammatory
      3. Oncology & Hematology
      4. Neurology
      5. Respiratory & Allergy
      6. Rare Diseases & Immunodeficiencies
      7. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
  8. Europe Subcutaneous Biologic Market Size Analysis
    1. Introduction
    2. Subcutaneous Biologic Market Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Peptides/Proteins
      3. Immunoglobulins
      4. Cytokines
      5. Oligonucleotides
      6. Enzymes/Hormones
      7. Others
    3. Subcutaneous Biologic Market Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
      1. Prefilled Syringes
      2. Autoinjector Pens
      3. Wearable Injectors
      4. Vial & Syringes
      5. Prefilled Cartridges for Pens
    4. Subcutaneous Biologic Market Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Metabolics
      2. Autoimmune & Inflammatory
      3. Oncology & Hematology
      4. Neurology
      5. Respiratory & Allergy
      6. Rare Diseases & Immunodeficiencies
      7. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
  9. APAC Subcutaneous Biologic Market Size Analysis
    1. Introduction
    2. Subcutaneous Biologic Market Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Peptides/Proteins
      3. Immunoglobulins
      4. Cytokines
      5. Oligonucleotides
      6. Enzymes/Hormones
      7. Others
    3. Subcutaneous Biologic Market Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
      1. Prefilled Syringes
      2. Autoinjector Pens
      3. Wearable Injectors
      4. Vial & Syringes
      5. Prefilled Cartridges for Pens
    4. Subcutaneous Biologic Market Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Metabolics
      2. Autoimmune & Inflammatory
      3. Oncology & Hematology
      4. Neurology
      5. Respiratory & Allergy
      6. Rare Diseases & Immunodeficiencies
      7. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
  10. Middle East and Africa Subcutaneous Biologic Market Size Analysis
    1. Introduction
    2. Subcutaneous Biologic Market Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Peptides/Proteins
      3. Immunoglobulins
      4. Cytokines
      5. Oligonucleotides
      6. Enzymes/Hormones
      7. Others
    3. Subcutaneous Biologic Market Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
      1. Prefilled Syringes
      2. Autoinjector Pens
      3. Wearable Injectors
      4. Vial & Syringes
      5. Prefilled Cartridges for Pens
    4. Subcutaneous Biologic Market Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Metabolics
      2. Autoimmune & Inflammatory
      3. Oncology & Hematology
      4. Neurology
      5. Respiratory & Allergy
      6. Rare Diseases & Immunodeficiencies
      7. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
  11. LATAM Subcutaneous Biologic Market Size Analysis
    1. Introduction
    2. Subcutaneous Biologic Market Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Peptides/Proteins
      3. Immunoglobulins
      4. Cytokines
      5. Oligonucleotides
      6. Enzymes/Hormones
      7. Others
    3. Subcutaneous Biologic Market Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
      1. Prefilled Syringes
      2. Autoinjector Pens
      3. Wearable Injectors
      4. Vial & Syringes
      5. Prefilled Cartridges for Pens
    4. Subcutaneous Biologic Market Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Metabolics
      2. Autoimmune & Inflammatory
      3. Oncology & Hematology
      4. Neurology
      5. Respiratory & Allergy
      6. Rare Diseases & Immunodeficiencies
      7. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      3. Market Size & Forecast By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      4. Market Size & Forecast By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
  12. Competitive Landscape
    1. Subcutaneous Biologic Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Hoffmann-La Roche Ltd (Switzerland)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson & Johnson (US)
    3. AbbVie Inc. (US)
    4. Amgen Inc. (US)
    5. Pfizer Inc. (US)
    6. Merck & Co., Inc. (US)
    7. Bristol Myers Squibb Company (US)
    8. AstraZeneca PLC (UK)
    9. Novartis AG (Switzerland)
    10. Sanofi S.A. (France)
    11. GSK plc (UK)
    12. UCB S.A. (Belgium)
    13. Regeneron Pharmaceuticals, Inc. (US)
    14. Biogen Inc. (US)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.